TREATMENT OF PEDIATRIC TYPE 2 DIABETES MELLITUS PATIENTS

The present invention refers to lixisenatide for use in pediatrics.

Saved in:
Bibliographic Details
Main Authors Bergmann, Karin, Jan, Christelle, Hincelin-Mery, Agnes
Format Patent
LanguageEnglish
Published 24.06.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention refers to lixisenatide for use in pediatrics.
Bibliography:Application Number: US202017028400